🇺🇸 FDA
Patent

US 8227494

Pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatment of disease

granted A61KA61K31/4245A61K31/4439

Quick answer

US patent 8227494 (Pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatment of disease) held by PTC THERAPEUTICS, INC. expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545